Advancing Cancer Research from the Ground Up: Introducing the Greehey CCRI Xenograft & Cell Lines Core

May 28, 2026

At the Greehey Children’s Cancer Research Institute (GCCRI), groundbreaking discoveries don’t just happen in theory—they are tested, refined, and brought closer to real-world impact through cutting-edge research platforms. One of the most powerful of these is the Xenograft & Cell Lines Core Facility, a cornerstone of GCCRI’s mission to accelerate new therapies for childhood cancer. [...]

Advancing Cancer Research: Introducing the Mouse Radiation Treatment Center (MRTC)

May 28, 2026

At the Greehey Children’s Cancer Research Institute (GCCRI), breakthrough discoveries don’t happen by chance—they’re powered by innovative tools, dedicated scientists, and a commitment to translating research into better outcomes for children with cancer. One of the Institute’s most powerful resources driving this mission forward is the Mouse Radiation Treatment Center (MRTC). 👉 Learn more: Mouse [...]

India Post: Manjeet Rao, PhD Recognized as “Indian American Cancer Scientists Honored with Prestigious SAASCR Awards for Pioneering Breakthroughs” (Rao)

May 14, 2026

REPOSTED from Original article: The Society of American Asian Scientists in Cancer Research (SAASCR) honored outstanding Indian American scientists for their pioneering contributions to cancer research on April 19, 2026, in San Diego. The awards were presented during the esteemed AACR (American Association for Cancer Research) Annual Meeting, highlighting transformative discoveries that are advancing the frontiers [...]

Recognizing Excellence in Radiation Research: Dr. Weixing Zhao Named Michael Fry Award Recipient

May 13, 2026

The Greehey Children’s Cancer Research Institute and UT Health San Antonio are proud to recognize Weixing Zhao, PhD, as a recipient of the prestigious Michael Fry Award, honoring outstanding early-career contributions to radiation research. Advancing Our Understanding of DNA Repair and Cancer Therapy Dr. Zhao serves as an Associate Professor in the Department of Biochemistry [...]

Panneerdoss Subbarayalu, PhD (Rao Lab) to Receive $879,000 American Cancer Society Grant

May 8, 2026

Panneerdoss Subbarayalu, PhD American Cancer Society Research Scholar Grant Information Principal Investigator: Panneerdoss Subbarayalu, PhD, Co-Investigators: Dr. Peter Houghton, Dr. Gail Tomlinson, Dr. Yidong Chen, Dr. Suryavathi Viswanadhapalli, and Dr. Hareesh Nair. Project Title: Novel Targeted Therapy for Treating Osteosarcoma with Lung Metastasis Funding Agency: American Cancer Society (ACS) Total Amount of Federal Funds Authorized: [...]

David Libich, PhD Awarded Five‑Year, $2.1 million NIH Grant to Study “Protein Intrinsic Disorder in Genome Regulation.”

April 13, 2026

Every cell in the body must carefully protect its DNA to stay healthy. To do this, cells coordinate several essential tasks, such as turning genes on and off, processing genetic information, and repairing damaged DNA. These activities occur within the cell nucleus, in small, flexible structures known as biomolecular condensates, which function as temporary workspaces without physical [...]

Graduate School of Biomedical Sciences (GSBS) Outstanding Student Awards

April 8, 2026

We at Greehey CCRI are proud to celebrate the exceptional achievements of our GSBS students, whose leadership and research are making a meaningful impact across our academic community. 🌟 GSBS Outstanding Student Leadership Award: Jack Prochnau The Outstanding Student Leadership Award honors a GSBS student who has demonstrated exceptional dedication and leadership through campus involvement, [...]

Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers (Sung)

April 8, 2026

Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in collaboration with Dana-Farber Cancer Institute at Harvard Medical School, Columbia University and Irving Medical Center, have made a critical breakthrough in understanding why cancers with BRCA1 mutations become resistant to a widely used class of drugs known as PARP inhibitors - pharmacological inhibitors of poly [...]

Congratulations to Elizabeth Wasmuth, PhD on Her UT Health SA Presidential Excellence Award

February 27, 2026

We are proud to celebrate Elizabeth V. Wasmuth, PhD, Assistant Professor and Howard Hughes Medical Institute Freeman Hrabowski Scholar in the Department of Biochemistry and Structural Biology, Long School of Medicine, for her outstanding achievements and recognition through the 2026 UT Health San Antonio Presidential Excellence Awards. Every day, our employees work tirelessly to advance [...]